TWITTER – DIGNITANA

Dignitana AB Publishes Q2 2022 Interim Report https://news.cision.com/dignitana-ab/r/dignitana-ab-publishes-q2-2022-interim-report,c3615908

Dignitana secures SEK 10 million line of credit from largest shareholder https://news.cision.com/dignitana-ab/r/dignitana-secures-sek-10-million-line-of-credit-from-largest-shareholder,c3587002

Dignitana announces American Medical Association reaffirms policy supporting scalp cooling https://news.cision.com/dignitana-ab/r/dignitana-announces-american-medical-association-reaffirms-policy-supporting-scalp-cooling,c3586951

Kommuniké från årsstämma i Dignitana AB (publ) https://news.cision.com/se/dignitana-ab/r/kommunike-fran-arsstamma-i-dignitana-ab--publ-,c3570454

Bulletin from the annual general meeting of Dignitana AB (publ) https://news.cision.com/dignitana-ab/r/bulletin-from-the-annual-general-meeting-of-dignitana-ab--publ-,c3570453

Load More

FACEBOOK – DIGNICAP

This message is only visible to admins.
Problem displaying Facebook posts. Backup cache in use.
Click to show error
Error: Invalid OAuth access token. Type: OAuthException

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

HEADQUARTERS
Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy